ArticleOncotarget2018

LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer.

Akihiro Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.